SM-102 is an ionisable cationic amino lipid that has been used in combination with other lipids in the formation of lipid nanoparticles (LNPs). Administration of luciferase mRNA in SM-102-containing LNPs induces hepatic luciferase expression in mice. Formulations containing SM-102 have been used in the development of LNPs for delivery of mRNA-based vaccines.
Cayman Chemical’s SM-102 is distributed in Australia and New Zealand by Sapphire Bioscience.
Online:
www.sapphirebioscience.com
Phone: 02 9698 2022
Phone: 02 9698 2022
Related Products
Cayman Chemical Off-Patent Drug Screening Library (96-Well)
Featuring a curated collection of FDA-approved compounds that are no longer covered under...
Norgen Biotek Bacterial EV Isolation Kit
The Bacterial EV Isolation Kit enables researchers to isolate extracellular vesicles directly...
Bertin Bioreagent Myelotracker kit for neutrophil detection
Bertin Bioreagent introduces Myelotracker, an innovative peptide-based probe specifically...
